SARS-CoV-2 Switches 'on' MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.

MLA

Goel, Swati, et al. “SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.” Frontiers in Pharmacology, vol. 11, Apr. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fphar.2021.631879.

APA

Goel, S., Saheb Sharif-Askari, F., Saheb Sharif Askari, N., Madkhana, B., Alwaa, A. M., Mahboub, B., Zakeri, A. M., Ratemi, E., Hamoudi, R., Hamid, Q., & Halwani, R. (2021). SARS-CoV-2 Switches “on” MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression. Frontiers in Pharmacology, 11, N.PAG. https://doi.org/10.3389/fphar.2021.631879

Chicago

Goel, Swati, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif Askari, Bushra Madkhana, Ahmad Munzer Alwaa, Bassam Mahboub, Adel M Zakeri, et al. 2021. “SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.” Frontiers in Pharmacology 11 (April): N.PAG. doi:10.3389/fphar.2021.631879.